Close

Billy Quilty

MSc

Research Assistant

Room
120

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Affiliations

Faculty of Epidemiology and Population Health
Department of Infectious Disease Epidemiology

Centres

Centre for the Mathematical Modelling of Infectious Diseases (CMMID)
Vaccine Centre

Research

My research is centred around estimating and evaluating the impact of pneumococcal conjugate vaccines (PCV) on childhood disease burden through spatial and mathematical modelling. This involves characterising important factors of pneumococcal epidemiology such as local serotype distribution and vaccine coverage, as well as socio-economic and environmental determinants.

Currently, I am investigating pneumococcal epidemiology in China as part of the NIHR Evidence to Policy pathway to Immunisation in China (EPIC) project. This project aims to help decision-makers in China develop a vaccination programme that ensures reliable, affordable, equitable and uninterrupted supply of vaccines to the Chinese population.

I also work on a trial assessing the viability of reduced-dosage schedules of PCV in Nha Trang, Vietnam. Reduced-dose schedules, if effective, would increase the affordability of PCV for countries in the process of graduating from Gavi support.

Research Area
Economic evaluation
Health care policy
Health impact analysis
Health inequalities
Infectious disease policy
Social and structural determinants of health
Vaccines
Bayesian Analysis
Equity
Geographic Information Systems (GIS)
Global Health
Immunisation
Impact evaluation
Spatial analysis
Modelling
Discipline
Health economics
Epidemiology
GIS/Spatial analysis
Mathematical modelling
Vaccinology
Disease and Health Conditions
Infectious disease
Malaria
Respiratory disease
Country
China
Vietnam

Selected Publications

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S
2020
The Lancet Global Health
Strategies to reduce the risk of SARS-CoV-2 re-introduction from international travellers
Clifford S; Quilty B; Russell T; Liu Y; Chan Y-WD; Pearson C; Eggo R; Endo A; Flasche S; Edmunds J
2020
Age-dependent effects in the transmission and control of COVID-19 epidemics.
Davies NG; Klepac P; Liu Y; Prem K; Jit M; CMMID COVID-19 working group; Eggo RM
2020
Nature medicine
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship.
Emery JC; Russell TW; Liu Y; Hellewell J; Pearson CA; CMMID COVID-19 Working Group; Knight GM; Eggo RM; Kucharski AJ; Funk S
2020
eLife
Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China
Endo A; Abbott S; Kucharski AJ; Funk S
2020
Wellcome Open Research
Using a real-world network to model localized COVID-19 control strategies.
Firth JA; Hellewell J; Klepac P; Kissler S; CMMID COVID-19 Working Group; Kucharski AJ; Spurgin LG
2020
Nature medicine
Quarantine and testing strategies in contact tracing for SARS-CoV-2
Quilty B; Clifford S; Flasche S; Kucharski A; Edmunds J; CMMID COVID-19 Working Group
2020
The effect of travel restrictions on the geographical spread of COVID-19 between large cities in China: a modelling study.
Quilty BJ; Diamond C; Liu Y; Gibbs H; Russell TW; Jarvis CI; Prem K; Pearson CAB; Clifford S; Flasche S
2020
BMC medicine
See more Publications